Regular ArticleSUBCUTANEOUS ADMINISTRATION OF RECOMBINANT GLYCOSYLATED INTERLEUKIN 6 IN PATIENTS WITH CANCER: PHARMACOKINETICS, PHARMACODYNAMICS AND IMMUNOMODULATORY EFFECTS
References (47)
- et al.
Effects of recombinant human interleukin-6 in cancer patients: A phase I-II study
Blood
(1994) - et al.
Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: A multicentric placebo-controlled, randomized phase Ib study
Blood
(1995) - et al.
A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia
Blood
(1995) - et al.
Tumour stimulating effects of recombinant human interleukin-6
Lancet
(1994) - et al.
Differential activation of the endogenous leukotriene biosynthesis by two different preparations of granulocyte-macrophage colony-stimulating factor in healthy volunteers
Blood
(1993) - et al.
Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity
J Biol Chem
(1990) - et al.
Phase I study of interleukin-6 in children with solid tumours in relapse
Eur J Cancer
(1997) - et al.
Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate—The marmoset
Blood
(1994) - et al.
Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons
Blood
(1992) - et al.
Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6
Blood
(1992)
A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130
Febs Lett
(1996)
High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro
Cytokine
(1993)
Pharmacokinetic study of anti-interleukin-6 (IL-6) therapy with monoclonal antibodies: enhancement of IL-6 clearance by cocktails of anti-IL-6 antibodies
Blood
(1995)
Transcriptional regulation of the human intercellular adhesion molecule-1 gene: a short overview
Immunobiol
(1995)
Interleukin-6 in biology and medicine
Adv Immunol
(1993)
Interleukin-6 and megakaryocytopoiesis: An update
Ann Hematol
(1996)
Interleukin-6: A cytokine with potential diagnostic and therapeutic roles
J Lab Clin Med
(1994)
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies
J Clin Oncol
(1993)
Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: Induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity
Cancer Immunol Immunother
(1994)
A phase I trial of intravenous interleukin-6 in patients with advanced cancer
J Immunother
(1994)
Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer
J Clin Oncol
(1995)
A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease
Leuk Lymph
(1997)
Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: Evidence for monocyte activation
J Immunother
(1996)
Cited by (0)
- f1
Correspondence to: Dr R. E. Banks, ICRF Cancer Medicine Research Unit, St James's University Hospital, Leeds LS9 7TF, UK
Copyright © 2000 Academic Press. All rights reserved.